Eukaryotic initiation factor 6 repression mitigates atherosclerosis progression by inhibiting macrophages expressing Fasn

Atherosclerosis, a chronic inflammatory disease that often leads to myocardial infarction and stroke, is mainly caused by lipid accumulation. Eukaryotic initiation factor 6 (Eif6) is a rate-limiting factor in protein translation of transcription factors necessary for lipogenesis. To determine whether Eif6 affects atherosclerosis, Eif6+/- mice were crossed into Apoe-/- background. Apoe-/-/Eif6+/- mice on high fat diet showed significant reduction in atherosclerotic lesions and necrotic core content in aortic root sections in comparison with Apoe-/- mice. RNA-Seq was used to investigate the effect of Eif6 in aorta. Deficiency of Eif6 shows broad effect on cell metabolism. Expression of genes for fatty acid synthesis including Fatty acid synthase (Fasn), Elovl3, Elovl6 and Acaca are down-regulated in aortas. Importantly, Fasn is decreased in macrophages. Results suggest that Eif6 deficiency may decrease atherosclerosis through inhibition of Fasn and lipids metabolism in macrophages.

[1]  C. Ke,et al.  eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma , 2022, Journal of translational medicine.

[2]  Hyo‐Soo Kim,et al.  Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation , 2019, Nature Chemical Biology.

[3]  Jeanne Kowalski,et al.  NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis , 2018, bioRxiv.

[4]  D. Tang,et al.  Research Progress on the Relationship between Atherosclerosis and Inflammation , 2018, Biomolecules.

[5]  H. Fuchs,et al.  High levels of eukaryotic Initiation Factor 6 (eIF6) are required for immune system homeostasis and for steering the glycolytic flux of TCR-stimulated CD4+ T cells in both mice and humans. , 2017, Developmental and comparative immunology.

[6]  G. Hansson,et al.  The immunology of atherosclerosis , 2017, Nature Reviews Nephrology.

[7]  Wei Zhu,et al.  The role of eukaryotic translation initiation factor 6 in tumors , 2017, Oncology letters.

[8]  Dan Liu,et al.  Progression of atherosclerosis in ApoE-knockout mice fed on a high-fat diet. , 2016, European review for medical and pharmacological sciences.

[9]  Wei Wei,et al.  Effects of the eukaryotic initiation factor 6 gene on expression levels of inflammatory mediators in M2 macrophages during scar repair. , 2016, Molecular medicine reports.

[10]  Weifeng He,et al.  Eukaryotic initiation factor 6 modulates myofibroblast differentiation at transforming growth factor-β1 transcription level via H2A.Z occupancy and Sp1 recruitment , 2015, Journal of Cell Science.

[11]  Peter K. Davidsen,et al.  eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription , 2015, Nature Communications.

[12]  S. Ricciardi,et al.  eIF6 anti-association activity is required for ribosome biogenesis, translational control and tumor progression. , 2015, Biochimica et biophysica acta.

[13]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[14]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[15]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[16]  S. Biffo,et al.  Eukaryotic initiation factor 6 mediates a continuum between 60S ribosome biogenesis and translation , 2009, EMBO reports.

[17]  H. Kiyokawa,et al.  Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation , 2008, Nature.

[18]  Ruiqiang Li,et al.  SOAP: short oligonucleotide alignment program , 2008, Bioinform..

[19]  J. Menéndez,et al.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.

[20]  P. Zaragoza,et al.  Association of polymorphisms in the bovine FASN gene with milk-fat content. , 2006, Animal genetics.

[21]  H. Abdi.  The Bonferonni and Šidák Corrections for Multiple Comparisons , 2006 .

[22]  D. Chlubek,et al.  Dietary trans fatty acids and composition of human atheromatous plaques , 2004, European journal of nutrition.

[23]  F. Sanvito,et al.  Isolation of a Novel β4 Integrin-binding Protein (p27BBP) Highly Expressed in Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[24]  D. Russell,et al.  Mechanism of action of the wheat germ ribosome dissociation factor: interaction with the 60 S subunit. , 1980, Archives of biochemistry and biophysics.